We're developing technologies to replicate cancer patients' disease ex-vivo to rapidly and accurately test a broad range of treatments simultaneously to help oncologists provide the most suitable treatment for each patient and pharmaceutical companies develop transformational therapies.
Location: Argentina, Autonomous City of Buenos Aires
Employees: 11-50
Total raised: $6.85M
Founded date: 2020
Investors 2
| Date | Name | Website |
| 30.01.2023 | Creative V... | creativeve... |
| - | Endless Fr... | endlessfro... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 01.11.2022 | Seed | $3.3M | - |
| 31.07.2022 | Seed | $3.3M | - |
| 16.02.2021 | Pre-Seed | $250K | IndieBio |
Mentions in press and media 3
| Date | Title | Description |
| 01.11.2022 | OncoPrecision Raises $3.3M in Seed Funding | OncoPrecision, a New York, NY and Córdoba, Argentina-based Patient Micro Avatar technology company, raised $3.3m in Seed funding. The round, closed in April, was led by SOSV’s IndieBio, GRIDX, New York Ventures (the venture capital arm of t... |
| 31.10.2022 | OncoPrecision Raises $3.3M Seed Funding | NEW YORK, NY, OncoPrecision announces $3.3 million in Seed Funding. >> Click here for more funding data on OncoPrecision >> To export OncoPrecision funding data to PDF and Excel, click here OncoPrecision announces $3.3 mi... |
| 17.03.2021 | From improving cancer treatments to saving the bees, these are the companies in IndieBio’s latest class | Ultra-precise cancer therapies! Human-like hair grown from plants! A way to potentially save the bees! The spectrum of companies coming out of IndieBio has always been pretty wild, and its latest batch definitely doesn’t disappoint. As the ... |